Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apimeds Pharmaceuticals US, Inc. Common Stock (NY:APUS)

3.080 -0.810 (-20.82%)
Official Closing Price Updated: 4:10 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 262,115
Open 4.000
Bid (Size) 2.900 (100)
Ask (Size) 3.260 (1,800)
Prev. Close 3.890
Today's Range 2.740 - 4.029
52wk Range 1.430 - 4.031
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire

Performance

YTD
+77.0%
+77.0%
1 Month
+69.2%
+69.2%
3 Month
+76.0%
+76.0%
6 Month
+77.0%
+77.0%
1 Year
+77.0%
+77.0%

More News

Read More
News headline image
Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist College of Business
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
From Apimeds Pharmaceuticals US, Inc.
Via Business Wire

Frequently Asked Questions

Is Apimeds Pharmaceuticals US, Inc. Common Stock publicly traded?
Yes, Apimeds Pharmaceuticals US, Inc. Common Stock is publicly traded.
What exchange does Apimeds Pharmaceuticals US, Inc. Common Stock trade on?
Apimeds Pharmaceuticals US, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock?
The ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock is APUS on the New York Stock Exchange
What is the current price of Apimeds Pharmaceuticals US, Inc. Common Stock?
The current price of Apimeds Pharmaceuticals US, Inc. Common Stock is 3.080
When was Apimeds Pharmaceuticals US, Inc. Common Stock last traded?
The last trade of Apimeds Pharmaceuticals US, Inc. Common Stock was at 11/18/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.